Becton, Dickinson and Company (BDX)
Medical - Instruments & Supplies · Healthcare · $41.0B
Intrinsic Value (Consensus)
$81.89
Current Price
$144.01
Margin of Safety
-43.1%
43.1% Above Intrinsic Value
Value: $82
Price: $144
Valuation Model Estimates
Current Price: $144.01
DCF (Discounted Cash Flow)
$106.52
Graham Number
$88.31
Earnings Power Value
$53.95
Relative Value (P/E)
$78.77
Dividend Discount Model
Not applicable
—
Consensus Value
$81.89
Model Assumptions
Discount Rate
10.3%
Growth Rate
8.2%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
55
Profitability
15/25
Strength
20/25
Valuation
7/25
Growth
13/25
Financial Health Signals
High free cash flow yield (9.5%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $3.94
- EPS (Forward)
- $4.26
- Book Value
- $88.00
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 6.6%
- Debt/Equity
- 69%
- Revenue Growth
- 8.2%
- Earnings Growth
- 8.2%
- Dividend Yield
- 1.8%
- Beta
- 0.22
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance